Learn More
MedChemExpress Sinapinic acid
Description
Rhizome, acts as an inhibitor of HDAC, with an IC50 of 2.27 mM, and also inhibits ACE-I activity. Sinapinic acid posssess potent anti-tumor activity, induces apoptosis of tumor cells. Sinapinic acid shows antioxidant and antidiabetic activities. Sinapinic acid reduces total cholesterol, triglyceride, and HOMA-IR index, and also normalizes some serum parameters of antioxidative abilities and oxidative damage in ovariectomized rats.
Specifications
Specifications
| Content And Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Weight (g/mol) | 224.21 g/mol |
| Shipping Condition | Room temperature |
| For Use With (Application) | Cancer-programmed cell death |
| CAS | 530-59-6 |
| Product Type | Natural Products |
| Purity | 98.9% |
| Solubility | DMSO : 100 mg/mL (446.01 mM∣Need ultrasonic) ∣Ethanol : 25 mg/mL (111.50 mM∣Need ultrasonic) |
| Synonym | Sinapic acid |
| Target | HDAC∣Angiotensin-converting Enzyme (ACE)∣Reactive Oxygen Species∣Apoptosis |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.